Various classes of drugs, like a, b, c yenu classes of drugs that are available. And give me if they made any recent changes
Asking for Preferences
Asking for Preferences
Drugs used in pregnancy, those classes
Reading File
Searching the Web
FDA pregnancy drug categories A B C D X PLLR 2015 changes
Searching PubMed
FDA pregnancy labeling rule PLLR drug categories
Finding Sources
Finding Sources
I now have enough information from the web search and my knowledge to give a thorough answer. Let me compile the full response.
FDA Pregnancy Drug Categories (The Old System - A, B, C, D, X)
This system was used from 1979 to 2015. Drugs were assigned a letter based on available evidence of fetal risk.
Category A
- Definition: Adequate, well-controlled studies in pregnant women show no risk to the fetus in the first trimester (and no evidence of risk in later trimesters).
- Examples: Folic acid, Levothyroxine (at normal doses), certain vitamins
- Implication: Considered safe for use in pregnancy.
Category B
- Definition: Animal studies show no fetal risk, but no adequate human studies exist; OR animal studies showed adverse effects but adequate human studies showed no risk.
- Examples: Metformin, Amoxicillin, Paracetamol (acetaminophen), Insulin, Ondansetron
- Implication: Generally considered safe based on available data.
Category C
- Definition: Animal studies show adverse fetal effects, but no adequate human studies; or no animal or human studies available. Benefits may justify use despite potential risks.
- Examples: Fluconazole (single dose), most antihypertensives (e.g., amlodipine), many antidepressants (SSRIs early in pregnancy)
- Implication: Use only if the potential benefit justifies the potential risk to the fetus. The largest group of drugs.
Category D
- Definition: There is positive evidence of human fetal risk, but benefits may be acceptable in life-threatening situations or serious disease.
- Examples: Phenytoin, Valproate, Tetracycline, Lithium, Alcohol (if labeled), ACE inhibitors (2nd/3rd trimester)
- Implication: Use only when no safer alternative exists.
Category X
- Definition: Studies (animal or human) show fetal abnormalities, or there is evidence of fetal risk based on reports, and the risks clearly outweigh any benefit.
- Examples: Thalidomide, Isotretinoin (Accutane), Warfarin, Methotrexate, Statins, Misoprostol (for non-obstetric use), Finasteride
- Implication: Absolutely contraindicated in pregnant women or women who may become pregnant.
The Big Change - PLLR (2015)
The Pregnancy and Lactation Labeling Rule (PLLR) came into effect on June 30, 2015, and the FDA officially retired the A/B/C/D/X letter system.
Why the change?
- The letter categories were oversimplified and often misleading - a "C" drug could mean animal data showed harm, or simply that no data existed at all, both very different situations.
- Clinicians and patients were making assumptions based on letter grades rather than actual risk-benefit analysis.
What replaced it?
The new labeling system uses three narrative subsections in the package insert:
| New Section | What it covers |
|---|---|
| 8.1 Pregnancy (includes Labor & Delivery) | Risk summary, clinical considerations, pregnancy exposure registry data, background risk data |
| 8.2 Lactation (formerly "Nursing Mothers") | Drug transfer into breast milk, effects on infant, advice for breastfeeding |
| 8.3 Females and Males of Reproductive Potential | Pregnancy testing requirements, contraception requirements, effects on fertility |
Key features of the PLLR:
- Requires narrative text with actual human data when available
- Must reference pregnancy exposure registries if they exist
- Labels must be updated when new safety information emerges
- Applies to all prescription drugs approved after June 30, 2001 (phased in by 2018)
- OTC (over-the-counter) drug labels were NOT changed under this rule
Quick Summary Table
| Old Category | Risk Level | Still Relevant? |
|---|---|---|
| A | No fetal risk (human data) | Yes, as a concept |
| B | No risk (animal), limited human data | Yes, as a concept |
| C | Uncertain / animal risk | Yes, as a concept |
| D | Proven human fetal risk, benefit may justify | Yes, as a concept |
| X | Contraindicated - risks outweigh benefits | Yes, as a concept |
The old A-X letter categories are no longer printed on drug labels for newer drugs, but they are still widely taught in medical education and used as a conceptual framework. Many older drug package inserts (approved before 2001) may still carry the old letter, as they were not required to reformat.
Practical note: For clinical practice today, always check the current drug label's narrative sections or a reference like Drugs.com pregnancy category guide or LactMed for lactation data rather than relying on the old letter alone.
This is a shared conversation. Sign in to Orris to start your own chat.